4/A//SEC Filing
THURMAN RANDY H 4/A
Accession 0001209191-20-051048
CIK 0001649989other
Filed
Sep 16, 8:00 PM ET
Accepted
Sep 17, 7:20 PM ET
Size
6.0 KB
Accession
0001209191-20-051048
Insider Transaction Report
Form 4/AAmended
THURMAN RANDY H
Director
Transactions
- Award
Stock Option (Right to Buy)
2020-07-17+154,555→ 154,555 totalExercise: $1.58Exp: 2030-07-17→ Common Stock (154,555 underlying)
Footnotes (1)
- [F1]The options were granted under the Issuer's 2015 Equity Incentive Plan (the "2015 Plan") and shall vest in full on July 17, 2021, subject to the Reporting Person providing continuous service to the Issuer on such date and subject to acceleration upon a Change in Control as defined in the 2015 Plan, subject to the Reporting Person providing continuous service to the Issuer through such event.
Documents
Issuer
Outlook Therapeutics, Inc.
CIK 0001649989
Entity typeother
Related Parties
1- filerCIK 0001204059
Filing Metadata
- Form type
- 4/A
- Filed
- Sep 16, 8:00 PM ET
- Accepted
- Sep 17, 7:20 PM ET
- Size
- 6.0 KB